Biodexa Pharmaceuticals Plc - BDRX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | Reduced | 14,809 | 43 | 0.0% | 0.0% | 1 | -82,712 | -84.81% | Q2 2026 | Aug 14, 2026 |
| GAMMA Investing LLC | History | Reduced | 1,203 | 3 | 0.0% | 0.0% | 2 | -12,577 | -91.27% | Q2 2026 | Jul 07, 2026 |
| Allied Private Wealth LLC | History | New | 489 | 1 | 0.0% | — | 3 | +489 | New | Q2 2026 | Jul 09, 2026 |
| SABBY MANAGEMENT, LLC | History | Closed out | 0 | 0 | — | 0.35% | — | -257,472 | -100.0% | Q2 2026 | Aug 14, 2026 |
| SBI Securities Co., Ltd. | History | Reduced | 29 | 0 | — | — | — | -122 | -80.79% | Q2 2026 | Jul 22, 2026 |
| UBS Group AG | History | Reduced | 25 | 0 | — | — | — | -102 | -80.31% | Q2 2026 | Aug 13, 2026 |
| Hilton Head Capital Partners, LLC | History | Reduced | 6 | 0 | — | — | — | -24 | -80.0% | Q2 2026 | Jul 27, 2026 |
| RHUMBLINE ADVISERS | History | Reduced | 3 | 0 | — | — | — | -16 | -84.21% | Q2 2026 | Aug 11, 2026 |
| Caitong International Asset Management Co., Ltd | History | Added to | 5 | 0 | — | — | — | +4 | 400.0% | Q2 2026 | Aug 04, 2026 |